Accepted at 7:10 a.m. Feb, 26, 2024 by herstein.jacob
Author: thomas.holmes
Co-authors: herstein.jacob
Related Note: 1488765299956
Rationale for change

re-arranged answers so preferred treatment is first

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::10_Anticoagulation #AK_Step2_v12::#SketchySurgery::02_Trauma,_Burns,_Critical_Care::04_Head_and_Neck_Trauma::05_Moderate_and_Severe_Traumatic_Brain_Injury_2_Management #AK_Step1_v12::#UWorld::COMLEX::23821 #AK_Step2_v12::#SketchyIM::00_Sketchy_Pearls::01_Clinical_Basics::02_Blood_Bank_Review #AK_Step2_v12::Original_decks::Zanki_Step_2::Neuro::UW_Neuro #AK_Step1_v12::#FirstAid::05_Pharm::03_Toxicities_and_Adverse_Effects::03_Specific_toxicity_treatments #AK_Step2_v12::!Shelf::EM #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::03_Warfarin #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::07_Anticoagulant_Drugs::Extra #AK_Step2_v12::#AMBOSS::wN0hWg #AK_Step2_v12::Original_decks::Dorian::neuro::uw #AK_Step1_v12::#UWorld::COMLEX::24559 #AK_Step2_v12::#SketchyIM::10_Gastroenterology::Retired_Lesson::05_GI_Bleeding::02_Acute_Upper_GI_Bleed_Esophageal_Non_Varices_Bleeding_[OLD_VERSION] #AK_Step2_v12::#AMBOSS::xx0EAR #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::01_Bleeding_Disorders:_Coagulation_Factor_Disorders_DDx #AK_Step2_v12::#SketchyIM::10_Gastroenterology::05_GI_Bleeding::01_Acute_Upper_GI_Bleed:_Esophageal_Varices #AK_Step2_v12::#CMS::Pediatrics::Form_08 #AK_Step2_v12::#SketchySurgery::02_Trauma,_Burns,_Critical_Care::03_Abdominal_Trauma::01_Hemorrhage_and_Hypovolemic_Shock #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step2_v12::#Resources_by_rotation::Neuro::uw::dorian #AK_Step2_v12::#UWorld::Step::4601 #AK_Step1_v12::#UWorld::Step::1448 #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::03_Antiplatelet,_Anticoagulant,_Thrombolytic_Agents #AK_Step2_v12::#UWorld::COMLEX::101384 #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::02_Warfarin #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::03_Heparin_vs_warfarin::*Warfarin #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::02_Warfarin #PANCE::GI::toxic_substance_ingestion #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#AMBOSS::#Self_Assessment #AK_Step1_v12::#UWorld::Step::709 #AK_Step2_v12::#Subjects::Hematology::01_Hemostasis::04_Hypercoagulable_State::Warfarin_Skin_Necrosis #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::05_Anticoagulants #AK_Step2_v12::#AMBOSS::9x0NAR #AK_Step1_v12::#AMBOSS::M5aMkO #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Other::#AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step2_v12::#Resources_by_rotation::Neuro::uw::zanki #AK_Step3_v12::#UWorld::5668 #AK_Step1_v12::#Bootcamp::Biochemistry::12_Vitamins::06_Vitamin_K_Clinical_Implications #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::01_Warfarin #AK_Step2_v12::Original_decks::Dorian::im::uw::neuro #AK_Step2_v12::#UWorld::COMLEX::100532 #AK_Step2_v12::#UWorld::Step::3737 #PANCE::EOR::Family_med